Chinese drug maker Kintor Pharmaceutical on Friday made its trading debut on the Main Board of the Hong Kong stock exchange after an HK$1.86 billion ($240 million) initial public offering (IPO).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
